This review discussesthe potential targets that can be used for designing and implementingprecision medicine in RA treatment, spotlighting the latest breakthroughsin biologics, JAK inhibitors, IL-6 receptor antagonists, TNF blockers,and disease-modifying noncoding RNAs. The gene discussed is TNF; the disease is rheumatoid arthritis.